-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The synthesis of pharmaceuticals and other chemical products is a complex process that involves the use of various chemicals and methods.
One of the important molecules used in this process is 1-Boc-4-(4-methoxycarbonylphenyl)piperazine, which is commonly used as an intermediate in the synthesis of certain pharmaceuticals.
The synthetic routes of this molecule have been extensively studied and developed over the years, and this article will explore some of the most commonly used synthetic routes for 1-Boc-4-(4-methoxycarbonylphenyl)piperazine.
One of the most commonly used synthetic routes for 1-Boc-4-(4-methoxycarbonylphenyl)piperazine is the Widner-Masson synthesis.
This synthesis involves the reaction of 1,4-dioxan-2-one with 4-methoxybenzaldehyde in the presence of an acid catalyst to form an intermediate aldol condensation product.
The product is then treated with hydrogen chloride in the presence of a Lewis acid catalyst to form the desired 1-Boc-4-(4-methoxycarbonylphenyl)piperazine.
Another commonly used synthetic route for 1-Boc-4-(4-methoxycarbonylphenyl)piperazine is the Ehrlich-Danheiser synthesis.
This synthesis involves the reaction of benzaldehyde with N,N-dimethylformamide and then with 1-bromo-4-piperidone in the presence of a base to form the desired piperazine intermediate.
The intermediate is then treated with hydrogen chloride in the presence of an acid catalyst to form the desired 1-Boc-4-(4-methoxycarbonylphenyl)piperazine.
A third synthetic route for 1-Boc-4-(4-methoxycarbonylphenyl)piperazine is the P2P synthesis.
This synthesis involves the reaction of 4-methoxybenzaldehyde with sodium hydride in the presence of an N-protected amino acid to form an intermediate aldol condensation product.
The product is then treated with hydrogen chloride in the presence of an acid catalyst to form the desired 1-Boc-4-(4-methoxycarbonylphenyl)piperazine.
Each of these synthetic routes has its own advantages and disadvantages, and the selection of the best route will depend on various factors, such as the availability and cost of the starting materials, the desired yield and purity of the product, and the scale of the synthesis.
In addition, the use of modern synthetic methodologies, such as organocatalysis, microwave irradiation, and flow chemistry, has also been explored for the synthesis of 1-Boc-4-(4-methoxycarbonylphenyl)piperazine, with the aim of improving efficiency, safety, and sustainability.
In conclusion, the synthetic routes for 1-Boc-4-(4-methoxycarbonylphenyl)piperazine have been extensively studied and developed over the years, and various synthetic methods have been developed to meet the needs of the pharmaceutical industry.
As the demand for new drugs and chemical products continues to grow, the development of new and efficient synthetic routes for 1-Boc-4-(4-methoxycarbonylphenyl)piperazine and other important pharmaceutical building blocks will remain an important area of research and development in the chemical industry.